178 related articles for article (PubMed ID: 34904114)
1. Heart failure as an adverse effect of infliximab for Crohn's disease: A case report and review of the literature.
Grillo TG; Almeida LR; Beraldo RF; Marcondes MB; Queiróz DAR; da Silva DL; Quera R; Baima JP; Saad-Hossne R; Sassaki LY
World J Clin Cases; 2021 Nov; 9(33):10382-10391. PubMed ID: 34904114
[TBL] [Abstract][Full Text] [Related]
2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
3. A Remarkable Response of Granulomatous Hypophysitis to Infliximab in a Patient With a Background of Crohn's Disease-A Case Report.
Force BK; Vogel TP; Nguyen DM; Heck KA; Sebastian S; Takashima M; Yoshor D; Samson SL
Front Endocrinol (Lausanne); 2020; 11():350. PubMed ID: 32547497
[No Abstract] [Full Text] [Related]
4. Lymphomatoid Papulosis Type B in a Patient with Crohn's Disease Treated with TNF-Alpha Inhibitors Infliximab and Adalimumab.
Medvecz M; Kiss N; Hársing J; Kuroli E; Hegede G; Csomor J; Kárpáti S; Marschalkó M
Acta Dermatovenerol Croat; 2019 Sep; 27(3):202-204. PubMed ID: 31542070
[TBL] [Abstract][Full Text] [Related]
5. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
6. Coexisting Crohn's Disease and Takayasu's Arteritis in Two Patients Treated with Anti-TNF-α Therapies.
Ratuapli S; Mazlumzadeh M; Gurudu S; Money S; Heigh R
Case Rep Gastroenterol; 2010 Feb; 4(1):35-40. PubMed ID: 21103225
[TBL] [Abstract][Full Text] [Related]
7. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
8. A rare case of free bowel perforation associated with infliximab treatment for stricturing Crohn's disease.
Lim CS; Moon W; Park SJ; Park MI; Kim HH; Kim JB; Choi JM; Chang HK; Lee SH
Korean J Gastroenterol; 2013 Sep; 62(3):169-73. PubMed ID: 24077628
[TBL] [Abstract][Full Text] [Related]
9. Hemorrhagic pericardial effusion following treatment with infliximab: A case report and literature review.
Li H; Xing H; Hu C; Sun BY; Wang S; Li WY; Qu B
World J Clin Cases; 2021 Sep; 9(25):7593-7599. PubMed ID: 34616831
[TBL] [Abstract][Full Text] [Related]
10. Early intestinal obstruction after infliximab therapy in Crohn's disease.
Chiba M; Tanaka Y; Ono I
Autops Case Rep; 2019; 9(1):e2018068. PubMed ID: 30863735
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate for induction of remission in refractory Crohn's disease.
McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
[TBL] [Abstract][Full Text] [Related]
12. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
Gordon M; Taylor K; Akobeng AK; Thomas AG
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010233. PubMed ID: 25081347
[TBL] [Abstract][Full Text] [Related]
13. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study.
Armuzzi A; Felice C; Papa A; Marzo M; Pugliese D; Andrisani G; Federico F; De Vitis I; Rapaccini GL; Guidi L
J Crohns Colitis; 2013 Dec; 7(12):e623-9. PubMed ID: 23810678
[TBL] [Abstract][Full Text] [Related]
14. Adalimumab for orbital myositis in a patient with Crohn's disease who discontinued infliximab: a case report and review of the literature.
Verma S; Kroeker KI; Fedorak RN
BMC Gastroenterol; 2013 Apr; 13():59. PubMed ID: 23556424
[TBL] [Abstract][Full Text] [Related]
15. Oral ulcerations are associated with the loss of response to infliximab in Crohn's disease.
Sánchez AR; Rogers RS; Sheridan PJ
J Oral Pathol Med; 2005 Jan; 34(1):53-5. PubMed ID: 15610407
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of adalimumab in patients with Crohn's disease and failure to infliximab therapy: a clinical series.
Cordero Ruiz P; Castro Márquez C; Méndez Rufián V; Castro Laria L; Caunedo Álvarez A; Romero Vázquez J; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 2011 Jun; 103(6):294-8. PubMed ID: 21736395
[TBL] [Abstract][Full Text] [Related]
17. A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease.
Dretzke J; Edlin R; Round J; Connock M; Hulme C; Czeczot J; Fry-Smith A; McCabe C; Meads C
Health Technol Assess; 2011 Feb; 15(6):1-244. PubMed ID: 21291629
[TBL] [Abstract][Full Text] [Related]
18. Dilated Cardiomyopathy in Pediatric Crohn's Patient: Is It a Manifestation or Consequence of Therapy?
Busaleh F; Albaqshi H; AlSultan S; Alateeq S; Alhashim LA; Aldandan Z; Alfarhan N
Cureus; 2021 Nov; 13(11):e19357. PubMed ID: 34925971
[TBL] [Abstract][Full Text] [Related]
19. Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-alpha antagonists.
Curtis JR; Kramer JM; Martin C; Saag KG; Patkar N; Shatin D; Burgess M; Xie A; Braun MM
Rheumatology (Oxford); 2007 Nov; 46(11):1688-93. PubMed ID: 17938138
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive review and update on Crohn's disease.
Gajendran M; Loganathan P; Catinella AP; Hashash JG
Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
